SOZO

Multiple entities use the name SOZO. ImpediMed, the developer of the SOZO Digital Health Platform, has offices in Carlsbad, California. Sozos Health is based in the US. Sozo Ventures, a venture capital firm that invests in healthcare IT, has offices in Redwood City, California, and Tokyo, Japan. SOZO Global Inc. is located in Austin, Texas, USA.  All Japan companies → — Founded Multiple entities use the name SOZO. ImpediMed, the developer of the SOZO Digital Health Platform, was founded in 1999. Sozo Ventures was formed in 2012. SOZO HEALTHCARE LLP was incorporated on June 27, 2017.
Medical Device / Hardware Specialty-Focused AI Wearables / RPM
Multiple entities use the name SOZO. Sozo Ventures invests in companies from Seed to Series C stage, and also supports businesses from seed to pre-IPO stages.

Products

SOZO
SOZO
Clinical Decision Support & Reference
SOZO by ImpediMed is a non-invasive bioimpedance spectroscopy (BIS) device designed for the early detection and ongoing management of lymphedema, providing rapid L-Dex scores and body composition analysis.

See all 1 product →

About SOZO

SOZO refers to several entities in the healthcare AI space, each with distinct focuses. One prominent entity is the SOZO Digital Health Platform, developed by ImpediMed. This platform utilizes bioimpedance spectroscopy (BIS) to provide non-invasive, precise assessments of fluid status and tissue composition. It is FDA-cleared for sarcopenia risk assessment and is used in aesthetic medicine to support weight loss, IV, and body contouring programs, as well as for fluid monitoring and tracking treatment response. The platform aims to offer objective, clinically validated body composition outputs and personalized progress reports to enhance patient engagement and treatment adherence.

Another entity, Sozos Health, focuses on personalized medication management. Their platform combines genetics with patent-pending technology (TruTYPE) to identify medications with a high probability of not working effectively, aiming to reduce preventable drug interactions. This is particularly beneficial for patients with multiple chronic illnesses, those on numerous medications, or high-risk populations. Sozos Health’s pharmacy wellness platform and mobile app assist both patients and healthcare professionals in identifying non-successful medications.

Additionally, “SOZO” can refer to SOZO Intuition, a real-time intelligence platform for biotechnology. This platform helps make sense of developments in biotech by tracking company news, enabling technology, and mapping therapeutic pipelines by disease indication. It offers personalized feeds and weekly digests for users to stay informed about relevant companies, technologies, and focus areas. There’s also Sozo AI, which focuses on deploying autonomous AI agents to learn business operations, follow procedures, and collaborate with human teams in dynamic enterprise environments.

Focus Areas

Multiple entities use the name SOZO. The SOZO Digital Health Platform (by ImpediMed) focuses on body composition and fluid analytics including sarcopenia risk assessment weight management IV programs and body contouring. Sozos Health focuses on personalized medication management utilizing genetics and patent-pending technology to reduce preventable drug interactions. SOZO Intuition focuses on real-time biotechnology intelligence including company news technology tracking and therapeutic pipelines. Sozo Ventures invests in healthcare IT advanced data technologies e-commerce enterprise cloud fintech and IoT. Sozo AI focuses on deploying autonomous AI agents for core business functions in dynamic enterprise environments.

Business Intelligence

TechnologyBioimpedance Spectroscopy (BIS) technology

What Physicians Need to Know

SOZO Digital Health Platform (by ImpediMed)
Specializes in body composition and fluid analytics, including sarcopenia risk assessment, weight management, IV programs, and body contouring. It utilizes Bioimpedance Spectroscopy (BIS) technology to provide real-time, non-invasive insights into fluid status and tissue composition in under 30 seconds. The platform is FDA-cleared and can be used for early detection of lymphedema, monitoring heart failure, and comprehensive body composition analysis.
Sozos Health
Focuses on personalized medication management by combining genetics and patent-pending technology (TruTYPE) to reduce preventable drug interactions. They aim to identify non-successful medications and provide insights into how a patient's body processes prescriptions, including potential side effects or non-therapeutic responses.
SOZO Intuition
Specializes in real-time biotechnology intelligence, including company news, technology tracking, and therapeutic pipelines. While the prompt describes SOZO Intuition, the search results for "SOZO Intuition" primarily refer to ConcertAI, which focuses on accelerating insights and improving patient outcomes through advanced real-world data (RWD) and AI technologies, particularly in oncology. Their solutions include tools for smarter trial design, patient matching, and real-time insights, as well as advanced imaging.
Sozo Ventures
An investment firm that backs technology-enabled ventures with a focus on global expansion, particularly for US firms entering the Japanese market. They invest in category leaders transforming global industries with advanced data technologies, e-commerce, enterprise cloud, fintech, IoT, and healthcare IT.
Sozo AI
Focuses on deploying autonomous AI agents for core business functions in dynamic enterprise environments. In the healthcare context, autonomous AI agents are emerging to assist with clinical workflows, such as taking patient histories, ordering and interpreting tests, generating differential diagnoses, and formulating treatment plans within electronic health record (EHR) systems.
Physician Tip

For the **SOZO Digital Health Platform (ImpediMed)**, physicians can leverage its rapid, non-invasive BIS technology for early detection and monitoring of conditions like lymphedema and heart failure, and for comprehensive body composition analysis to inform weight management and other programs. The immediate results and trend tracking provide personalized patient data for confident clinical decision-making.

For **Sozos Health**, physicians can utilize their personalized medication management platform, which combines genetics and patent-pending TruTYPE technology, to reduce preventable drug interactions and optimize medication regimens. This can lead to improved patient outcomes by identifying medications with the most probable risk of not working properly, and by providing insights into potential side effects or non-therapeutic responses.

For **SOZO Intuition** (as described by ConcertAI), physicians in oncology can benefit from advanced real-world data and AI technologies for smarter trial design, patient matching, and real-time insights, enhancing cancer care delivery.

For **Sozo AI**, while autonomous AI agents are still evolving, physicians can anticipate tools that streamline administrative tasks, assist with research, and potentially aid in clinical decision-making within EHR systems, freeing up more time for patient care. It's important to start with low-risk workflows and ensure human oversight and adherence to safety and privacy standards.

The SOZO Digital Health Platform (ImpediMed) offers a cloud-based platform (MySOZO) where patient data is accessible across care teams and can be integrated with EHRs for auto-documentation. Sozos Health's pharmacy wellness platform and mobile app are designed to help patients and healthcare professionals, and they work with providers to integrate their approach into practice workflows. For autonomous AI agents (Sozo AI), integration into EHR systems is a key aspect, allowing them to operate within clinical workflows and execute permitted actions.

Products by SOZO

1 product in the directory

SOZO
SOZO
Clinical Decision Support & Reference
SOZO by ImpediMed is a non-invasive bioimpedance spectroscopy (BIS) device designed for the early detection and ongoing management of lymphedema, providing rapid L-Dex scores and body composition analysis.

What the Web Says

SOZO appears to be a brand name used by several different companies across various industries, leading to mixed reviews. There's a healthcare technology company (ImpediMed's SOZO Digital Health Platform) focused on lymphedema detection and body composition, a brain center offering non-invasive neuromodulation techniques, a past multi-level marketing (MLM) beverage company, and a skincare brand. Employee reviews for some entities named "SoZo" or "SoZo Global" on Indeed generally indicate issues with management, organization, and communication, with some employees advising against working there. Product reviews for a beverage called "Sozo" on Reddit were largely negative, citing high prices and artificial taste. In contrast, the SOZO Brain Center receives overwhelmingly positive feedback for its staff, service, and treatments. The SOZO Digital Health Platform is praised by medical professionals for its utility in patient care.

Overall: Mixed

Strengths

  • SOZO Digital Health Platform is FDA-cleared and non-invasively measures fluid status and tissue composition, aiding in lymphedema detection and overall health optimization.
  • SOZO Brain Center has professional, kind, and attentive staff.
  • SOZO Brain Center offers effective, evolutionary treatments for neurological, chronic, and mental health conditions.
  • SOZO Brain Center provides informative educational workshops and seminars.
  • Some employees at SoZo Global found it a great workplace with nice people, despite being unorganized.
  • The Sozo Read app is a free, open-source manga and novel reader with multiple sources, offline downloads, cloud sync, and no ads.

Limitations

  • Some SoZo (beverage) products are considered overpriced and do not taste like real fruit.
  • Employee reviews for some SoZo entities mention bad management, lack of organization, and contradictory directions.
  • Some employees felt chastised for showing knowledge and were let go without reason.
  • Issues with job security and advancement were noted in some SoZo employee reviews.
  • The former Sozo MLM company had concerns about autoship requirements and a focus away from retail sales.
  • Some ZO skincare products are considered overpriced, and results may vary.

Based on reviews from: Reddit, Indeed.com, YouTube, ImpediMed, BehindMLM, Trustpilot

Last updated: 2026-10-18

Videos

News, demos, and interviews about SOZO.

Loading videos...

Videos load interactively. If none appear, search YouTube for SOZO →

View all on YouTube

Press & Coverage

ImpediMed Limited (ASX:IPD) - Listcorp
SOZO Pro Achieves Clearance by U.S. FDA
ImpediMed Limited announced that its next-generation bioimpedance spectroscopy (BIS) system, SOZO Pro, received clearance from the U.S. Food & Drug Administration (FDA). The SOZO Pro offers new features like an integrated weight scale and higher standing weight capacity to improve clinical workflow and expand testing to more patients.
2023-05
PRNewswire
SOZO® Digital Health Platform Receives FDA Clearance for Sarcopenia Risk Assessment
ImpediMed received U.S. FDA 510(k) clearance for sarcopenia risk assessment on its SOZO® Digital Health Platform, making it the only FDA-cleared bioimpedance spectroscopy (BIS) solution for this purpose. This expanded indication allows clinicians to detect sarcopenia risk from the same rapid SOZO scan used for lymphedema and body composition monitoring.
2026-08
ImpediMed
AstraZeneca Selects SOZO for Heart Failure & Renal Trials Key Highlights
ImpediMed announced a contract valued at over AUD $2 million for its SOZO® Digital Health Platform to be used in a clinical trial for AstraZeneca, a global biopharmaceutical company. This trial will provide cardiologists with firsthand experience using SOZO for fluid measurement accuracy in heart failure and renal trials.
2020-09
SOZO Brain Center
Inside SOZO Conference 2025: Transforming Brain Health Globally
The 2nd Annual SOZO Neuromodulation Conference in Vienna brought together experts to explore cutting-edge neuromodulation therapies, with a focus on global partnerships and initiatives planned for 2026 to expand SOZO Brain Center's reach. The CEO, Matthew Papadopoulos, highlighted the company's mission to 'save people, give them back dignity, hope, and meaning in life' through neuromodulation.
2025-12
CancerNetwork
The Routine Use of Bioimpedance Spectroscopy Measurements in the Clinic as a Surrogate for Bone Mineral Content in Oncology Patients: Practical Application of the SOZO Device
This article discusses the practical application of ImpediMed's SOZO BIS device as a noninvasive tool to measure fluid and body composition, including skeletal muscle mass (SMM), in oncology patients. Studies show a strong correlation between SOZO SMM and bone mineral content, suggesting its use as a surrogate for tracking changes in bone health during cancer treatment.
2022-05
ImpediMed Medical Bioimpedance Spectroscopy Devices
ImpediMed Broadens Breast Cancer Survivorship Monitoring with the SOZO® Digital Health Platform at ASBrS 2026
ImpediMed continues to expand its breast cancer survivorship monitoring capabilities with the SOZO® Digital Health Platform. The platform utilizes FDA-cleared Bioimpedance Spectroscopy (BIS) technology to non-invasively measure fluid status and tissue composition, providing real-time insights for personalized care.
2026-05
PRNewswire
SOZO™ Launched - First Product for Health and Wellness Markets
ImpediMed Limited launched SOZO™, the first product on its new population health platform, which combines bioimpedance spectroscopy (BIS) technology with artificial intelligence to provide rapid, non-invasive scans of body composition, fluid status, and hydration. This platform is designed to help consumers and patients track their health and wellness goals.
2016-08
PRNewswire
ImpediMed Receives FDA 510(k) Clearance of SOZO® for Expanded Indication
ImpediMed Limited received a 510(k) clearance for SOZO® from the U.S. FDA, making it the first device cleared for use as an aid in the assessment of Protein Calorie Malnutrition. This expanded clearance allows for marketing SOZO to assess patients at risk of PCM and track body composition over time.
2019-12

Frequently Asked Questions

The SOZO Digital Health Platform, developed by ImpediMed, is the entity focused on body composition and fluid analytics, offering tools for sarcopenia risk assessment, weight management, and more. When seeking solutions in this area, verify that you are interacting with ImpediMed's SOZO platform to ensure you access the correct products and services.
The SOZO Digital Health Platform provides advanced body composition and fluid analytics. Its offerings include tools for sarcopenia risk assessment, comprehensive weight management programs, optimization of IV programs, and support for body contouring. These tools can enhance patient care by providing precise data for personalized treatment plans and improved health outcomes.
While specific compliance details would need to be confirmed directly with ImpediMed, healthcare technology platforms like the SOZO Digital Health Platform are generally designed to adhere to stringent healthcare regulations and data privacy standards such as HIPAA. This includes secure data handling, encryption, and access controls to protect patient information.
Pricing for the SOZO Digital Health Platform typically involves a combination of hardware costs and recurring software or service fees, which can vary based on the scale of implementation and specific features utilized. ImpediMed generally provides comprehensive support, including initial training for staff, ongoing technical assistance, and educational resources to ensure effective integration and use within a clinical setting.
Integration capabilities with existing EHR systems are crucial for seamless clinical workflows; therefore, it is common for such platforms to offer or be working towards these integrations. As for company stability, ImpediMed, the developer of the SOZO Digital Health Platform, is an established medical technology company, suggesting a stable foundation for long-term support and product evolution.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]

PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]

NeurixaHealthAI™ is a healthcare AI company dedicated to eliminating administrative waste in the healthcare system, which they estimate to be $1.1 trillion annually. They offer a production-ready healthcare intelligence platform designed to simplify operations, improve outcomes, and accelerate the journey from patient care to financial performance. The platform is not a collection of point solutions […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.